Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

NCT00014937 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

240

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: lopinavir/ritonavir
DRUG: lamivudine/zidovudine
DRUG: efavirenz
DRUG: lamivudine
DRUG: stavudine
DRUG: zidovudine
DRUG: didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)